Today: 27 June 2026

Varonis stock rebounds after 11% slide as fresh shareholder lawsuit filing hits tape

Varonis stock rebounds after 11% slide as fresh shareholder lawsuit filing hits tape

Varonis Systems shares rose about 2.4% to $21.59 Tuesday morning after plunging 11% the previous day. A law firm said a securities class action was filed for investors who bought between Feb. 4 and Oct. 28, 2025, with a lead-plaintiff deadline set for March 9. The company remains under scrutiny as it shifts to SaaS subscriptions and faces a projected $30–$50 million 2026 revenue hit from government clients not converting.
24 February 2026
MongoDB stock drops again after 11% rout as tariffs, AI jitters loom ahead of March 2 earnings

MongoDB stock drops again after 11% rout as tariffs, AI jitters loom ahead of March 2 earnings

MongoDB shares fell 3.8% to $293.81 by 9:31 a.m. ET Tuesday, extending Monday’s 11.4% drop amid a broader selloff in software stocks. Investors cited uncertainty over tariffs and fears that new artificial intelligence tools could threaten parts of the software sector. MongoDB will report quarterly results after markets close on March 2. The S&P 500 software and services index is down nearly 24% year-to-date.
Tenable stock price wobbles near 52-week lows as AI fears rattle cybersecurity names

Tenable stock price wobbles near 52-week lows as AI fears rattle cybersecurity names

Tenable shares closed down nearly 12% at $17.55 on Monday, hitting fresh 52-week lows after Anthropic launched an AI security tool targeting open-source code. The stock was little changed in premarket trading Tuesday, with heavy volume following the sector-wide selloff. Investors are watching for further moves at the open and a March 3 company presentation for signs of demand and competition.
RingCentral stock steadies before the bell after 12% slide as Piper Sandler lifts target

RingCentral stock steadies before the bell after 12% slide as Piper Sandler lifts target

RingCentral shares rose 0.6% to $34.79 in premarket trading Tuesday after a 12.5% drop Monday and a 34% jump Friday. Piper Sandler raised its price target to $37 but kept a neutral rating, citing pricing pressure and dilution risk. The board approved a quarterly dividend of $0.075 per share, payable March 16 to holders as of March 9. Investors are watching if the post-earnings rally holds.
24 February 2026
IBM stock steadies before the bell after Anthropic’s COBOL AI claim sparks worst day since 2000

IBM stock steadies before the bell after Anthropic’s COBOL AI claim sparks worst day since 2000

IBM shares rose 0.7% in premarket trading Tuesday after plunging 13% Monday, their steepest drop since 2000. The selloff followed Anthropic’s claim that its Claude Code AI tools can speed up COBOL modernization, raising concerns over IBM’s mainframe services. IBM pushed back, saying platform modernization is more complex than code translation. Investors are watching IBM’s March 3 conference for further comments.
Stoke Therapeutics stock swings premarket after Wolfe starts coverage with $40 target (STOK)

Stoke Therapeutics stock swings premarket after Wolfe starts coverage with $40 target (STOK)

Stoke Therapeutics shares dropped 1.2% to $35.80 in early premarket trading Tuesday, after a 5.7% gain the previous session. Wolfe Research began coverage with an “Outperform” rating and a $40 price target. Investors are watching for updates on the company’s Phase 3 Dravet syndrome trial with Biogen. About 21.6% of Stoke’s float is sold short, according to MarketBeat.
IREN stock wobbles in premarket after Monday’s jump as MSCI rebalance nears

IREN stock wobbles in premarket after Monday’s jump as MSCI rebalance nears

IREN Limited shares fell 1.5% to $41.72 in premarket trading Tuesday, after jumping nearly 6% Monday ahead of its addition to the MSCI USA Index. Cantor Fitzgerald disclosed holdings of 3.47 million shares and put options on 5.03 million shares. Bitcoin dropped 5.3% to $62,693, pressuring crypto-linked stocks. IREN recently reported $2.8 billion in cash and secured $3.6 billion in GPU financing for a Microsoft contract.
24 February 2026
AngloGold Ashanti stock jumps 6% to a fresh high as gold swings and dividend dates come into focus

AngloGold Ashanti stock jumps 6% to a fresh high as gold swings and dividend dates come into focus

AngloGold Ashanti shares closed up 6% at $121.12 Monday after gold surged on U.S. tariff headlines, then slipped Tuesday as bullion prices fell over 1%. The company corrected a dividend date error, confirming March 13, 2026, as the record date. AngloGold recently reported a near tripling in annual profit and new reserves at its Nevada project.
24 February 2026
Equinox Gold stock swings as dividend and buyback plans collide with softer gold prices

Equinox Gold stock swings as dividend and buyback plans collide with softer gold prices

Equinox Gold shares closed up 6.25% in Toronto on Monday after the company declared its first quarterly dividend and applied for a share buyback. U.S.-listed shares last traded at $17.85, up about 6% after hours. The company reported net debt of $75 million at Jan. 31 after reducing debt by $1.1 billion since mid-2025. Gold prices fell over 1% on Tuesday, posing a near-term challenge for miners.
NESR stock rises premarket as National Energy Services Reunited pushes into fresh 52-week highs

NESR stock rises premarket as National Energy Services Reunited pushes into fresh 52-week highs

NESR shares rose 2.5% to $26.70 in premarket trading Tuesday after a 6.8% jump the prior session, nearing the top of their 52-week range. The company reported Q4 revenue of $398.3 million and adjusted EPS of $0.32, beating estimates, but net income fell to $7.8 million due to impairment and restructuring charges. Management is scheduled to meet investors at conferences in Houston and Las Vegas.
Dianthus Therapeutics (DNTH) stock rises ahead of TD Cowen conference; what investors watch next

Dianthus Therapeutics (DNTH) stock rises ahead of TD Cowen conference; what investors watch next

Dianthus Therapeutics shares rose 6.3% to $52.68 Monday ahead of CEO Marino Garcia’s scheduled fireside chat at TD Cowen’s health care conference on March 3. Volume reached about 944,000 shares. Investors are watching for updates on the company’s autoimmune pipeline and trial timelines. The event will be webcast and include one-on-one investor meetings.
Bloom Energy stock slips before the open after 9% rally — here’s what traders are watching

Bloom Energy stock slips before the open after 9% rally — here’s what traders are watching

Bloom Energy shares fell 1.6% to $157.80 in premarket trading Tuesday after an 8.6% surge the previous session. Director Jeffrey Immelt disclosed gifting 4,000 shares in a late Monday SEC filing. Tariff uncertainty and Nvidia’s results this week are influencing AI-linked stock moves. Bloom’s 2026 revenue forecast stands at up to $3.3 billion, with a reported backlog of about $20 billion.
24 February 2026
Legend Biotech (LEGN) stock slips in premarket after 9% surge as Gilead-Arcellx deal spotlights Carvykti rivals

Legend Biotech (LEGN) stock slips in premarket after 9% surge as Gilead-Arcellx deal spotlights Carvykti rivals

Legend Biotech shares slipped 0.2% to $19.72 in premarket trading Tuesday after a 9% jump the previous session, following news of Gilead’s $7.8 billion deal to buy Arcellx. The acquisition put focus on rival CAR-T therapies, with Arcellx’s anito-cel under FDA review and analysts citing possible safety advantages over Legend’s Carvykti, which generated $1.9 billion in 2025 sales.
24 February 2026
Viking Therapeutics stock (VKTX) slips in premarket after 11% rally as Novo obesity-drug stumble hits tape

Viking Therapeutics stock (VKTX) slips in premarket after 11% rally as Novo obesity-drug stumble hits tape

Viking Therapeutics shares fell 0.5% to $34.30 in premarket trading Tuesday after an 11.1% surge Monday, as investors reacted to new obesity drug trial data from Novo Nordisk. Novo’s CagriSema showed less weight loss than Eli Lilly’s rival drug, shaking the sector. Viking plans to advance its oral obesity drug VK2735 into late-stage trials in Q3. Investors await updates at upcoming healthcare conferences in March and April.
Bank of America stock steadies premarket after Monday’s drop as tariff jitters rattle banks

Bank of America stock steadies premarket after Monday’s drop as tariff jitters rattle banks

Bank of America shares were little changed in premarket trading Tuesday after closing down 3.75% amid a broad selloff in bank stocks. The KBW Regional Banking Index dropped 4.26% Monday as Treasury yields swung and investors weighed tariff headlines. JPMorgan, Wells Fargo, and Morgan Stanley each fell about 4%. U.S. stock futures edged higher early Tuesday ahead of key earnings and policy events.

Stock Market Today

  • Billionaire Ron Baron Predicts $50,000 Investment in SpaceX Could Soar in 10 Years
    June 27, 2026, 1:33 PM EDT. Billionaire investor Ron Baron, founder of Baron Capital, forecasts significant growth for SpaceX (NASDAQ: SPCX). Baron, who made $8 billion from Tesla investments, holds a $2.7 billion stake in SpaceX after its IPO, valuing the company around $2 trillion. He highlights SpaceX's lead in satellites, rockets, and network infrastructure, particularly its Starlink internet service targeting global coverage with plans for 100,000 satellites. Baron predicts Starlink could generate $1 trillion in annual revenue within a decade. A $50,000 investment in SpaceX today, according to Baron, could yield substantial returns as the company expands its technological and market presence.

Latest articles

IRS tax preparer fraud case draws investor attention to 75 million paid returns

IRS tax preparer fraud case draws investor attention to 75 million paid returns

27 June 2026
The Supreme Court let stand a ruling allowing the IRS unlimited time to assess taxes on returns tainted by preparer fraud, even if the taxpayer was unaware, spotlighting risk for 75 million paid-preparer e-filed returns and raising the stakes for firms like H&R Block and Intuit as investors watch the growing share and complexity of assisted tax filings.
US equities this week: AI chip slide grabs focus as rest of market holds up

US equities this week: AI chip slide grabs focus as rest of market holds up

27 June 2026
Investors yanked nearly $20 billion from technology funds in the week to June 24, reversing last week’s record inflows, as the PHLX semiconductor index plunged 7.9% for its worst week since April, raising fresh questions about AI profits and capital spending while S&P 500 and Nasdaq posted sharp weekly declines. (Reuters)
Go toTop